| Unique ID issued by UMIN | UMIN000054767 |
|---|---|
| Receipt number | R000062587 |
| Scientific Title | Efficacy and safety of inspiratory muscle training in hospitalized patients with acute-phase decompensated acute heart failure: A prospective single-arm study compared to historical control data. |
| Date of disclosure of the study information | 2024/06/25 |
| Last modified on | 2024/08/04 15:48:17 |
Efficacy and safety of inspiratory muscle training in hospitalized patients with acute-phase decompensated acute heart failure: A prospective single-arm study compared to historical control data.
IMT-AHF-single arm study
Efficacy and safety of inspiratory muscle training in hospitalized patients with acute-phase decompensated acute heart failure: A prospective single-arm study compared to historical control data.
IMT-AHF-single-arm study
| Japan |
Hospitalization patients with acute heart failure
| Rehabilitation medicine |
Others
NO
To clarify the efficacy and safety of inspiratory muscle training in hospitalized patients with acute heart failure.
Efficacy
2-minute walk distance
The safety of inspiratory muscle training
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
1) Patients admitted due to a diagnosis of acute heart failure and prescribed cardiac rehabilitation by a physician.
2) Patients who have inspiratory muscle weakness on examination at the start of cardiac rehabilitation
3) Patients who are implementable the 2-minute walk test on the examination at the start of cardiac rehabilitation.
1) inability to walk independently before admission
2) severe heart failure requiring intensive care such as circulatory support, ventilator, noninvasive positive pressure ventilation, hemodialysis, and intra-aortic balloon pumping
3) severe aortic valve stenosis
4) obstructive hypertrophic cardiomyopathy
5) poorly controlled arrhythmia causing hemodynamic abnormalities
6) inability to measure inspiratory muscle strength due to severe respiratory muscle weakness or the presence of a respiratory or neuromuscular disease that affects respiratory muscle strength (e.g., chronic obstructive pulmonary disease, myasthenia gravis)
7) impairment due to stroke, injury, or other medical condition that precludes participation in the measurement
8) anticipated hospital discharge before baseline study measures could be completed.
49
| 1st name | Ren |
| Middle name | |
| Last name | Takahashi |
Hirosaki University Graduate School of Health Sciences
Division of Comprehensive Rehabilitation Sciences
036-8564
Honcho 66-1, Hirosaki, Aomori
022-293-1111
h24dh405@hirosaki-u.ac.jp
| 1st name | Ren |
| Middle name | |
| Last name | Takahashi |
Hirosaki University Graduate School of Health Sciences
Division of Comprehensive Rehabilitation Sciences
036-8564
Honcho 66-1, Hirosaki, Aomori
022-293-1111
h24dh405@hirosaki-u.ac.jp
Hirosaki University Graduate School of Health Sciences
None
Self funding
Hirosaki University Graduate School of Health Sciences Ethics Committee
Honcho 66-1, Hirosaki, Aomori
0172-33-5111
jm5910@hirosaki-u.ac.jp
NO
| 2024 | Year | 06 | Month | 25 | Day |
Unpublished
39
No longer recruiting
| 2022 | Year | 11 | Month | 01 | Day |
| 2022 | Year | 12 | Month | 12 | Day |
| 2022 | Year | 11 | Month | 20 | Day |
| 2024 | Year | 03 | Month | 31 | Day |
| 2024 | Year | 03 | Month | 31 | Day |
| 2024 | Year | 03 | Month | 31 | Day |
Cohort study, subject recruitment method (all patients who visited our facility between November 2022 and March 2024 and met the inclusion criteria), historical control group used as control group,
| 2024 | Year | 06 | Month | 25 | Day |
| 2024 | Year | 08 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062587